Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.
Azam L
,
McIntosh JM
.
???displayArticle.abstract???
The α9α10 nicotinic acetylcholine receptor (nAChR) may be a potential target in pathophysiology of the auditory system, chronic pain, and breast and lung cancers. Alpha-conotoxins, from the predatory marine snail Conus, are potent nicotinic antagonists, some of which are selective for the α9α10 nAChR. Here, we report a two order of magnitude species difference in the potency of α-conotoxin RgIA for the rat versus human α9α10 nAChR. We investigated the molecular mechanism of this difference. Heterologous expression of the rat α9 with the human α10 subunit in Xenopus oocytes resulted in a receptor that was blocked by RgIA with potency similar to that of the rat α9α10 nAChR. Conversely, expression of the human α9 with that of the rat α10 subunit resulted in a receptor that was blocked by RgIA with potency approaching that of the human α9α10 receptor. Systematic substitution of residues found in the human α9 subunit into the homologous position in the rat α9 subunit revealed that a single point mutation, Thr56 to Ile56, primarily accounts for this species difference. Remarkably, although the α9 nAChR subunit has previously been reported to provide the principal (+) binding face for binding of RgIA, Thr56 is located in the (-) complementary binding face.
Adams,
Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels.
2012, Pubmed
Adams,
Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels.
2012,
Pubmed
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009,
Pubmed
Armishaw,
Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads.
2010,
Pubmed
Azam,
Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.
2009,
Pubmed
Azam,
Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
2006,
Pubmed
Azam,
Alpha-conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors.
2005,
Pubmed
,
Xenbase
Baker,
Pharmacological properties of alpha 9 alpha 10 nicotinic acetylcholine receptors revealed by heterologous expression of subunit chimeras.
2004,
Pubmed
,
Xenbase
Bourne,
Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors.
2005,
Pubmed
Brejc,
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
2001,
Pubmed
Cartier,
A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors.
1996,
Pubmed
,
Xenbase
Celie,
Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant.
2005,
Pubmed
,
Xenbase
Chernyavsky,
Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization.
2007,
Pubmed
Chikova,
Naturally occurring variants of human Α9 nicotinic receptor differentially affect bronchial cell proliferation and transformation.
2011,
Pubmed
Chikova,
New associations of the genetic polymorphisms in nicotinic receptor genes with the risk of lung cancer.
2012,
Pubmed
Clark,
The three-dimensional structure of the analgesic alpha-conotoxin, RgIA.
2008,
Pubmed
Dowell,
Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors.
2003,
Pubmed
,
Xenbase
Dutertre,
Toxin insights into nicotinic acetylcholine receptors.
2006,
Pubmed
Elgoyhen,
Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells.
1994,
Pubmed
,
Xenbase
Elgoyhen,
The efferent medial olivocochlear-hair cell synapse.
2012,
Pubmed
Elgoyhen,
alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells.
2001,
Pubmed
,
Xenbase
Ellison,
Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
2008,
Pubmed
Ellison,
Alpha-RgIA: a novel conotoxin that specifically and potently blocks the alpha9alpha10 nAChR.
2006,
Pubmed
,
Xenbase
Gómez-Casati,
Biophysical and pharmacological characterization of nicotinic cholinergic receptors in rat cochlear inner hair cells.
2005,
Pubmed
Gotti,
Heterogeneity and complexity of native brain nicotinic receptors.
2007,
Pubmed
Gotti,
Brain nicotinic acetylcholine receptors: native subtypes and their relevance.
2006,
Pubmed
Haberberger,
Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult rat.
2004,
Pubmed
Halai,
Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
2009,
Pubmed
,
Xenbase
Han,
Conus venoms - a rich source of peptide-based therapeutics.
2008,
Pubmed
Hansen,
Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
2005,
Pubmed
Harvey,
Determinants of specificity for alpha-conotoxin MII on alpha3beta2 neuronal nicotinic receptors.
1997,
Pubmed
,
Xenbase
Holtman,
The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic.
2011,
Pubmed
,
Xenbase
Janes,
alpha-Conotoxins as selective probes for nicotinic acetylcholine receptor subclasses.
2005,
Pubmed
Kasheverov,
Naturally occurring and synthetic peptides acting on nicotinic acetylcholine receptors.
2009,
Pubmed
Klimis,
A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain.
2011,
Pubmed
Kumar,
Nicotinic acetylcholine receptor subunits and associated proteins in human sperm.
2005,
Pubmed
Kurzen,
Phenotypical and molecular profiling of the extraneuronal cholinergic system of the skin.
2004,
Pubmed
Lee,
Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces α9-nicotinic acetylcholine receptor expression in human breast cancer cells.
2011,
Pubmed
Lee,
Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells.
2010,
Pubmed
Le Novère,
Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells.
1995,
Pubmed
Lester,
Cys-loop receptors: new twists and turns.
2004,
Pubmed
Lewis,
Conus venom peptide pharmacology.
2012,
Pubmed
Lips,
Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons.
2002,
Pubmed
Livett,
Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor.
2006,
Pubmed
Lustig,
Molecular cloning and mapping of the human nicotinic acetylcholine receptor alpha10 (CHRNA10).
2001,
Pubmed
McIntosh,
A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
2005,
Pubmed
,
Xenbase
McIntosh,
Alpha9 nicotinic acetylcholine receptors and the treatment of pain.
2009,
Pubmed
,
Xenbase
Millar,
Diversity of vertebrate nicotinic acetylcholine receptors.
2009,
Pubmed
Millard,
Structure-activity relationships of alpha-conotoxins targeting neuronal nicotinic acetylcholine receptors.
2004,
Pubmed
Muttenthaler,
Structure-activity studies on alpha-conotoxins.
2011,
Pubmed
Nguyen,
Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes.
2004,
Pubmed
Nguyen,
Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity.
2000,
Pubmed
Olivera,
Subtype-selective conopeptides targeted to nicotinic receptors: Concerted discovery and biomedical applications.
2008,
Pubmed
Peng,
Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes.
2004,
Pubmed
Pérez,
Molecular modeling of the alpha9alpha10 nicotinic acetylcholine receptor subtype.
2009,
Pubmed
Quiram,
Identification of residues in the neuronal alpha7 acetylcholine receptor that confer selectivity for conotoxin ImI.
1998,
Pubmed
Satkunanathan,
Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones.
2005,
Pubmed
Sgard,
A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit.
2002,
Pubmed
,
Xenbase
Shiembob,
Determinants of alpha-conotoxin BuIA selectivity on the nicotinic acetylcholine receptor beta subunit.
2006,
Pubmed
Tu,
Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced α9-nicotinic acetylcholine receptor upregulation in human breast cancer cells.
2011,
Pubmed
Ulens,
Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP.
2006,
Pubmed
Vetter,
Role of alpha9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation.
1999,
Pubmed
Vincler,
Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors.
2006,
Pubmed
Vincler,
Targeting the alpha9alpha10 nicotinic acetylcholine receptor to treat severe pain.
2007,
Pubmed
Wu,
Naturally-expressed nicotinic acetylcholine receptor subtypes.
2011,
Pubmed
Wu,
Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy.
2011,
Pubmed
Zheng,
Discovery of non-peptide, small molecule antagonists of α9α10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain.
2011,
Pubmed
